{
  "ticker": "OAK",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02975380",
  "id": "02975380",
  "pages": 8,
  "price_sensitive": true,
  "date": "20250731",
  "time": "1528",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250731/pdf/06md2drhmb3270.pdf",
  "summary": "### **Material Information Summary (Quarterly Report \u2013 Appendix 4C)**  \n\n#### **Financial & Operational Highlights:**  \n- **Revenue/Cash Flow:**  \n  - Cash receipts from customers: **$774k** (Q4), **$2.458m** (FY25; +126% YoY).  \n  - Net operating cash outflow: **($7k)** (Q4), **($394k)** (FY25).  \n- **Cash Position:**  \n  - Closing cash balance: **$471k** (vs. $504k last quarter).  \n  - Estimated funding runway: **67 quarters** (based on net operating cash burn).  \n\n#### **Business Performance:**  \n- **Sales Growth:** Exceeded budget, with strong project pipeline in aged care and healthcare sectors.  \n- **Strategic Initiatives:** Expanded partner network and product development (e.g., NuCaMS Enterprise, RTLS integration).  \n\n#### **Risks:**  \n- **Legal Exposure:** Potential claim from Teko International re: historical liabilities (~$250k placement in 2020). Outcome uncertain.  \n\n---  \n*Rule applied: Focused on quantifiable metrics, material risks, and operational catalysts. Omitted routine updates (e.g., marketing, HR).*",
  "usage": {
    "prompt_tokens": 4431,
    "completion_tokens": 261,
    "total_tokens": 4692,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-31T05:47:04.896614"
}